This autophagy-independent effect highlights quercetin’s potential as a therapeutic candidate for inflammatory diseases such as IBD and Kawasaki disease vasculitis by preventing NLRP3 inflammasome activation (200). The gene discussed is NLRP3; the disease is irritable bowel syndrome.